B&
Bruce & Co., Inc.
13F filer · CIK 0001358331Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$369MU.S. long equity reported on 13F
Positions390 new · 0 closed
Net flow last quarter-$6.36MBuys minus sells
Top 10 positions weight52.8%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 202639 positions | |||||
| $30.4M | 8.24% | 0.01% | -1.2% | Q2 2013 | |
| $29.1M | 7.89% | 0.05% | -2.4% | Q2 2013 | |
| $27M | 7.30% | 0.11% | +0.8% | Q3 2024 | |
| $24.1M | 6.51% | Not reported | -7.7% | Q4 2022 | |
| DEDUKDuke Energy CORP | $18.3M | 4.96% | 0.02% | -0.7% | Q3 2014 |
| $18.2M | 4.93% | 0.41% | -26.2% | Q3 2023 | |
| $14.7M | 3.97% | 0.03% | -1.1% | Q2 2013 | |
| $11.7M | 3.17% | 0.05% | -1.9% | Q3 2014 | |
| $10.7M | 2.90% | 0.01% | -1.0% | Q1 2022 | |
| $10.7M | 2.89% | 0.00% | -5.1% | Q1 2018 | |
| $10.4M | 2.82% | 1.48% | +20.9% | Q1 2026 | |
| $10.4M | 2.81% | 1.77% | Not reported | Q3 2017 | |
| $10.2M | 2.76% | 0.01% | -1.3% | Q2 2013 | |
| $9.34M | 2.53% | 0.01% | Not reported | Q2 2019 | |
| $8.18M | 2.21% | 0.24% | -0.7% | Q3 2014 | |
| $7.64M | 2.07% | 0.02% | Not reported | Q1 2024 | |
| $7.47M | 2.02% | 0.04% | Not reported | Q2 2013 | |
| $6.98M | 1.89% | 0.26% | +50.0% | Q2 2014 | |
| $6.46M | 1.75% | 0.00% | -1.4% | Q2 2013 | |
| $5.74M | 1.55% | 0.07% | -0.9% | Q3 2023 | |
| $5.65M | 1.53% | 0.23% | Not reported | Q1 2023 | |
| $5.13M | 1.39% | 0.17% | Not reported | Q1 2025 | |
| $4.75M | 1.29% | 0.04% | -1.8% | Q2 2013 | |
| $3.16M | 0.85% | 0.02% | Not reported | Q2 2025 | |
| $3.12M | 0.84% | 0.22% | Not reported | Q4 2022 | |
| $2.67M | 0.72% | 0.85% | +25.3% | Q4 2019 | |
| $2.4M | 0.65% | 0.00% | Not reported | Q4 2024 | |
| $2.36M | 0.64% | 0.04% | -2.0% | Q2 2013 | |
| $2.29M | 0.62% | 0.24% | Not reported | Q1 2026 | |
| $2.27M | 0.61% | 1.17% | Not reported | Q2 2013 | |
| $1.65M | 0.45% | 0.02% | Not reported | Q4 2014 | |
| $1.11M | 0.30% | Not reported | Not reported | Q1 2025 | |
| $988K | 0.27% | 0.03% | Not reported | Q2 2013 | |
| $916K | 0.25% | 0.01% | -1.0% | Q3 2021 | |
| $831K | 0.22% | 0.06% | Not reported | Q2 2018 | |
| VPVRXValeant Pharmaceuticals International | $611K | 0.17% | 0.16% | Not reported | Q2 2017 |
| $594K | 0.16% | 0.18% | Not reported | Q4 2022 | |
| $461K | 0.12% | 0.00% | Not reported | Q2 2024 | |
| $440K | 0.12% | 0.24% | Not reported | Q1 2023 | |
| Q1 2026Reported May 14, 202639 positions | |||||
| $26.6M | 7.62% | 0.01% | Not reported | Q2 2013 | |
| $25.6M | 7.33% | 0.05% | Not reported | Q2 2013 | |
| $25.2M | 7.20% | 0.11% | Not reported | Q3 2024 | |
| $20.2M | 5.77% | Not reported | Not reported | Q4 2022 | |
| DEDUKDuke Energy CORP | $19.1M | 5.46% | 0.02% | -6.4% | Q3 2014 |
| $15.2M | 4.34% | 0.01% | Not reported | Q1 2022 | |
| $14.7M | 4.19% | 0.03% | -5.1% | Q2 2013 | |
| $12.1M | 3.46% | 0.05% | Not reported | Q3 2014 | |
| $11.7M | 3.34% | 0.01% | Not reported | Q2 2013 | |
| $11.6M | 3.33% | 1.77% | Not reported | Q3 2017 | |
| $10.8M | 3.10% | 0.01% | Not reported | Q2 2019 | |
| $10.5M | 2.99% | 0.55% | -27.8% | Q3 2023 | |
| $9.87M | 2.82% | 0.00% | Not reported | Q1 2018 | |
| $8.9M | 2.55% | 0.04% | Not reported | Q2 2013 | |
| $8.09M | 2.31% | 0.24% | Not reported | Q3 2014 | |
| $7.63M | 2.18% | 0.00% | Not reported | Q2 2013 | |
| $7.27M | 2.08% | 0.02% | Not reported | Q1 2024 | |
| $6.56M | 1.87% | 0.07% | Not reported | Q3 2023 | |
| $5.53M | 1.58% | 0.23% | -12.1% | Q1 2023 | |
| $5.52M | 1.58% | 1.24% | New | Q1 2026 | |
| $5.51M | 1.58% | 0.17% | Not reported | Q1 2025 | |
| $5.17M | 1.48% | 0.17% | +21.8% | Q2 2014 | |
| $4.83M | 1.38% | 0.02% | Not reported | Q2 2025 | |
| $3.53M | 1.01% | 0.04% | Not reported | Q2 2013 | |
| $2.33M | 0.67% | 0.04% | Not reported | Q2 2013 | |
| $1.84M | 0.53% | 0.00% | Not reported | Q4 2024 | |
| $1.68M | 0.48% | 0.24% | New | Q1 2026 | |
| $1.63M | 0.47% | 1.17% | Not reported | Q2 2013 | |
| $1.58M | 0.45% | Not reported | Not reported | Q1 2025 | |
| $1.48M | 0.42% | 0.22% | Not reported | Q4 2022 | |
| $1.29M | 0.37% | 0.02% | Not reported | Q4 2014 | |
| $947K | 0.27% | 0.68% | +8.2% | Q4 2019 | |
| $834K | 0.24% | 0.03% | Not reported | Q2 2013 | |
| $787K | 0.23% | 0.01% | Not reported | Q3 2021 | |
| VPVRXValeant Pharmaceuticals International | $670K | 0.19% | 0.16% | Not reported | Q2 2017 |
| $478K | 0.14% | 0.06% | Not reported | Q2 2018 | |
| $475K | 0.14% | 0.26% | Not reported | Q1 2023 | |
| $457K | 0.13% | 0.00% | Not reported | Q2 2024 | |
| $418K | 0.12% | 0.18% | Not reported | Q4 2022 | |
| Q4 2025Reported Feb 13, 202637 positions | |||||
| $28M | 8.68% | 0.01% | -3.9% | Q2 2013 | |
| $26.4M | 8.18% | 0.11% | Not reported | Q3 2024 | |
| $26.1M | 8.10% | 0.05% | Not reported | Q2 2013 | |
| $21.1M | 6.55% | Not reported | Not reported | Q4 2022 | |
| DEDUKDuke Energy CORP | $18.3M | 5.66% | 0.02% | Not reported | Q3 2014 |
| $14.4M | 4.45% | 0.03% | Not reported | Q2 2013 | |
| $14.3M | 4.42% | 0.01% | -15.0% | Q2 2013 | |
| $13M | 4.03% | 0.01% | Not reported | Q1 2022 | |
| $10.9M | 3.38% | 0.05% | Not reported | Q3 2014 | |
| $10.9M | 3.37% | 1.77% | Not reported | Q3 2017 | |
| $10.6M | 3.28% | 0.00% | Not reported | Q1 2018 | |
| $9.99M | 3.10% | 0.01% | Not reported | Q2 2019 | |
| $9.86M | 3.06% | 0.77% | Not reported | Q3 2023 | |
| $7.77M | 2.41% | 0.25% | Not reported | Q3 2014 | |
| $6.77M | 2.10% | 0.00% | Not reported | Q2 2013 | |
| $6.24M | 1.93% | 0.04% | -12.5% | Q2 2013 | |
| $5.75M | 1.78% | 0.02% | Not reported | Q1 2024 | |
| $4.61M | 1.43% | 0.27% | -40.9% | Q1 2023 | |
| $4.08M | 1.27% | 0.14% | Not reported | Q2 2014 | |
| $3.82M | 1.18% | 0.07% | -19.1% | Q3 2023 | |
| $3.73M | 1.16% | 0.04% | Not reported | Q2 2013 | |
| $2.95M | 0.91% | 0.17% | Not reported | Q1 2025 | |
| $2.61M | 0.81% | 0.04% | Not reported | Q2 2013 | |
| $2.6M | 0.81% | 0.02% | Not reported | Q2 2025 | |
| $2.15M | 0.67% | 0.00% | Not reported | Q4 2024 | |
| $1.85M | 0.58% | 0.23% | -7.9% | Q4 2022 | |
| $1.44M | 0.45% | 1.17% | Not reported | Q2 2013 | |
| $1.12M | 0.35% | 0.02% | Not reported | Q4 2014 | |
| $1.11M | 0.34% | 0.06% | Not reported | Q2 2018 | |
| $880K | 0.27% | 0.03% | Not reported | Q2 2013 | |
| VPVRXValeant Pharmaceuticals International | $862K | 0.27% | 0.16% | -27.5% | Q2 2017 |
| $726K | 0.22% | 0.01% | Not reported | Q3 2021 | |
| $717K | 0.22% | 0.63% | Not reported | Q4 2019 | |
| $682K | 0.21% | Not reported | Not reported | Q1 2025 | |
| $416K | 0.13% | 0.00% | Not reported | Q2 2024 | |
| $398K | 0.12% | 0.26% | Not reported | Q1 2023 | |
| $359K | 0.11% | 0.19% | Not reported | Q4 2022 | |
| Q3 2025Reported Nov 13, 202537 positions | |||||
| $29.5M | 9.14% | 0.01% | Not reported | Q2 2013 | |
| $26.9M | 8.34% | 0.05% | Not reported | Q2 2013 | |
| $23M | 7.12% | Not reported | Not reported | Q4 2022 | |
| $22.2M | 6.88% | 0.10% | Not reported | Q3 2024 | |
| DEDUKDuke Energy CORP | $19.3M | 5.97% | 0.02% | -11.4% | Q3 2014 |
| $17.9M | 5.55% | 0.01% | Not reported | Q2 2013 | |
| $15.7M | 4.86% | 0.03% | Not reported | Q2 2013 | |
| $14.8M | 4.57% | 0.01% | -22.3% | Q1 2022 | |
| $13.2M | 4.08% | 1.77% | Not reported | Q3 2017 | |
| $11.4M | 3.54% | 0.05% | -20.4% | Q3 2014 | |
| $9.91M | 3.07% | 0.00% | Not reported | Q1 2018 | |
| $8.43M | 2.61% | 0.01% | Not reported | Q2 2019 | |
| $7.62M | 2.36% | 0.25% | Not reported | Q3 2014 | |
| $6.93M | 2.15% | 0.00% | Not reported | Q2 2013 | |
| $6.5M | 2.01% | 0.04% | Not reported | Q2 2013 | |
| $5.97M | 1.85% | 0.02% | Not reported | Q1 2024 | |
| $4.57M | 1.42% | 0.53% | -13.5% | Q1 2023 | |
| $4.47M | 1.39% | 0.77% | Not reported | Q3 2023 | |
| $4.22M | 1.31% | 0.04% | Not reported | Q2 2013 | |
| $4.04M | 1.25% | 0.08% | Not reported | Q3 2023 | |
| $3.96M | 1.23% | 0.17% | Not reported | Q1 2025 | |
| $3.92M | 1.22% | 0.14% | Not reported | Q2 2014 | |
| $2.94M | 0.91% | 0.02% | +50.0% | Q2 2025 | |
| $2.66M | 0.82% | 0.04% | Not reported | Q2 2013 | |
| $1.65M | 0.51% | 0.29% | Not reported | Q4 2022 | |
| $1.53M | 0.47% | 0.00% | Not reported | Q4 2024 | |
| $1.42M | 0.44% | Not reported | Not reported | Q1 2025 | |
| $1.3M | 0.40% | 0.02% | Not reported | Q4 2014 | |
| VPVRXValeant Pharmaceuticals International | $1.1M | 0.34% | 0.23% | Not reported | Q2 2017 |
| $1.05M | 0.32% | 0.06% | Not reported | Q2 2018 | |
| $1.01M | 0.31% | 1.17% | -20.8% | Q2 2013 | |
| $919K | 0.28% | 0.63% | +69.9% | Q4 2019 | |
| $719K | 0.22% | 0.03% | Not reported | Q2 2013 | |
| $598K | 0.19% | 0.19% | Not reported | Q4 2022 | |
| $583K | 0.18% | 0.27% | Not reported | Q1 2023 | |
| $577K | 0.18% | 0.01% | Not reported | Q3 2021 | |
| $452K | 0.14% | 0.00% | Not reported | Q2 2024 | |
Premium opens every quarter this fund has filed